Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary
- PMID: 38423809
- DOI: 10.1016/j.vaccine.2024.02.064
Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary
Abstract
Neisseria meningitidis causes life-threatening invasive meningococcal disease (IMD) with high mortality worldwide. Asymptomatic pharyngeal meningococcus colonisation is an important reservoir for the spread of the bacterium. The aim of this study was to determine N. meningitidis colonisation rates in asymptomatic high school and university students and to identify risk factors for carriage. Oropharyngeal swab samples and data from a self-reported questionnaire were obtained from overall 610 students, among them 303 university students and 307 high school students, aged between 15 and 31 years in Budapest, Hungary, between November 2017 and December 2018. Meningococcal carriage and serogroup of N. meningitidis were determined by RT-PCR from DNA extracted directly from the specimen. N. meningitidis was identified in 212 (34.8 %) of the participants. Significantly higher carriage rate was found among high school students (48.9 %) compared to university students (20.5 %). Peak of colonisation rate was among 17-19-year-old students (48.7 %). Most carriage isolates were non-typable (87.3 %). From the 212 meningococcus carriers, 19 were colonised by serogroup B (9 %), 5 by serogroup C (2.4 %), and 1 had serogroup Y (0.5 %). Significantly higher colonisation rate was found among males (42.4 %) than in females (33.1 %). Antibiotic use in the past 2 months has decreased the rate of meningococcal colonisation. Recent respiratory infection, active or passive smoking and attending parties have not influenced meningococcal colonisation rate significantly. In conclusion, we have found high asymptomatic meningococcus carriage rate among high school students and young adults, however, the majority of the colonizing meningococci were non-typable.
Keywords: Carriage; Colonisation; Hungary; MenB; Neisseria meningitidis; Risk factors; Young adults.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Epidemiological characteristics of invasive meningococcal disease and carriage prevalence of Neisseria meningitidis in the Xinjiang Uygur Autonomous Region, China, 2004-2023: a retrospective study.PeerJ. 2025 Jul 29;13:e19772. doi: 10.7717/peerj.19772. eCollection 2025. PeerJ. 2025. PMID: 40755789 Free PMC article.
-
Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.Eur J Med Res. 2025 Aug 5;30(1):710. doi: 10.1186/s40001-025-02926-4. Eur J Med Res. 2025. PMID: 40765002 Free PMC article. Review.
-
Geographical and temporal variations of serogroups and clonal types of Neisseria meningitidis involved in culture-confirmed invasive meningococcal disease in Canada, 2015-2023.J Med Microbiol. 2025 Mar;74(3):001979. doi: 10.1099/jmm.0.001979. J Med Microbiol. 2025. PMID: 40071600 Free PMC article.
-
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.Lancet Infect Dis. 2025 Apr;25(4):399-410. doi: 10.1016/S1473-3099(24)00576-0. Epub 2024 Nov 6. Lancet Infect Dis. 2025. PMID: 39521012 Clinical Trial.
-
Meningococcal carriage in high-risk settings: A systematic review.Int J Infect Dis. 2018 Aug;73:109-117. doi: 10.1016/j.ijid.2018.05.022. Epub 2018 Jul 8. Int J Infect Dis. 2018. PMID: 29997031
Cited by
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.Infect Dis Ther. 2025 Aug;14(8):1843-1865. doi: 10.1007/s40121-025-01190-7. Epub 2025 Jul 15. Infect Dis Ther. 2025. PMID: 40665158 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous